VivoSim Labs, INC. VIVS US Equity
$0.29
-0.01 (-2.63%)
USD · as of 2026-08-28 · marketstack
VivoSim Labs, INC. (Nasdaq: VIVS), an SEC filer in Biological Products, (No Diagnostic Substances), closed at $0.29, -2.6%, on 2026-08-28, with a market cap of $4M as of 2026-08-27, a return on equity of -35.3%, a net margin of -1727.8% and 3-year sales growth of -54.2%. Institutional ownership, earnings history and filed financials are on the tabs below.
| Date | Event | What happened / filer | Source |
|---|---|---|---|
| 2026-08-21 | 8-K 3.01 | Notice of delisting or failure to satisfy a listing rule | sec.gov ↗ |
| 2026-08-18 | 13G/A | Schedule 13G amendment — ≥5% beneficial owner (passive) · by Esousa Group Holdings LLC | sec.gov ↗ |
| 2026-08-06 | 8-K 2.02 | Results of operations and financial condition (earnings)earnings history (EARN) → | sec.gov ↗ |
| 2026-07-30 | 8-K 8.01 | Other events | sec.gov ↗ |
| 2026-07-30 | 8-K 5.08 | Shareholder director nominations | sec.gov ↗ |
| 2026-07-24 | 8-K 8.01 | Other events | sec.gov ↗ |
| 2026-07-24 | 8-K 3.01 | Notice of delisting or failure to satisfy a listing rule | sec.gov ↗ |
| 2026-07-17 | 8-K 8.01 | Other events | sec.gov ↗ |
| 2026-07-17 | 8-K 3.02 | Unregistered sales of equity securities | sec.gov ↗ |
| 2026-07-17 | 8-K 1.01 | Entry into a material definitive agreement | sec.gov ↗ |
Source: SEC EDGAR (public domain) · history starts 2026-07-17
Every row is a filed document, checked against its EDGAR index.